The DOI matches its Crossref record; 95 of the 100 references it cites were found in a registry or an index.
Subclinical Cushing’s syndrome in adrenal incidentalomas
Abstract
This article reviews the available evidence on subclinical Cushing's syndrome in patients who have adrenal incidentalomas. The authors' aim is to present up-to-date information on the most relevant issues of subclinical Cushing's syndrome by addressing the many uncertainties and controversies surrounding this ill-defined endocrine condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
From Adrenal incidentaloma (2020) · cites this paper as [215]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [203]
In the citing paper
“in our and other authors' experience (1), the presence of signs and/or symptoms of cortisol excess is extremely rare in patients referred for the presence of an AI.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“SH is estimated to be present in 5-30% of patients with adrenal masses serendipitously found by imaging for unrelated diseases [adrenal incidentalomas (AI)] (1,5).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Similarly, LDDST has been used to diagnose SH (18,40,41,55) without advantages, with the exception of patients affected with alcoholism, psychiatric disorders, and diabetes in whom this test may be more accurate (1,14,66).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The determination of ACTH levels after CRH does not seem to add any advantage (1,23,34,35,37,38,46) to screening for SH.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The reason to screen for SH with a higher cutoff than that recommended for overt cortisol excess [1.8 g/dl (50 nmol/liter)] (66) is that in patients without signs or symptoms suggestive of hypercortisolism, the a priori possibility of having SH is estimated to be lower than that of a false-positive result (1).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Therefore, UFC should not be considered an adequate screening test for SH and should be used in combination with other tests or in specific populations (1,14).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“Although it may reflect an autonomous ACTH-independent cortisol hypersecretion, available data do not demonstrate that low DHEAS concentration is a reliable index of SH (1,23,35), also considering that DHEAS levels decrease with age (77).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
In the citing paper
“The main pitfall of these studies is that the increased uptake of the radiotracer may simply reflect the presence of enlarged adrenal tissue rather than an increased cortisol secretion (1,35,78).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [1]
Citations
Cites
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,837
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475 · cited 1×
“Even if it is held that the metabolic syndrome is associated with enhanced all-cause and cardiovascular mortality [73,74], evidence of increased morbidity and mortality in patients who have clinically inapparent adrenal adenoma and subclinical Cushing’s syndrome or not, is lacking.”
BackgroundInsulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 7×
“The traditional threshold of 5 lg/dL (138 nmol/L) was recommended in the NIH consensus statement [ 2 ]; however, some experts proposed using lower cut points to increase the detection of subclinical hypercortisolism [55].”
BackgroundMethodInfluentialA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Incidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
How to measure insulin sensitivity
Ferrannini, E., & Mari, A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00001 · Cited by 510
Insulin Resistance and Cardiovascular Disease1
McFarlane, S. I., Banerji, M., & Sowers, J. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7202 · Cited by 505
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Rossi, R., Tauchmanovà, L., Luciano, A., Martino, M. D., Battista, C., Viscovo, L. D., Nuzzo, V., & Lombardi, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6515 · Cited by 416
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
Tauchmanovà, L., Rossi, R., Biondi, B., Pulcrano, M., Nuzzo, V., Palmieri, E.-A., Fazio, S., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011766 · Cited by 400
Insulin Resistance and Cardiovascular Disease
McFarlane, S. I. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.713 · Cited by 377
Incidentally discovered adrenal tumors: an institutional perspective.
Mf, H., Cs, G., van Heerden, J. A., Sheedy, P. F., & Dm, I. (1991) · PubMed · Cited by 356
Reincke, M., Nieke, J., Krestin, G. P., Saeger, W., Allolio, B., & Winkelmann, W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1517373 · Cited by 346
Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8277 · Cited by 322
Self-citationSubclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
Incidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 272
Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 255
Crucitti, F., Bellantone, R., Ferrante, A., Boscherini, M., & Crucitti, P. (1996) · Surgery · doi:10.1016/s0039-6060(96)80164-4 · Cited by 247
Papanicolaou, D. A., Yanovski, J. A., Cutler, G. B., Chrousos, G. P., & Nieman, L. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4733 · Cited by 235
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell-Price, J. D. C., Trainer, P. J., Perry, L., Wass, J. A. H., Grossman, A. B., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 222
Long-term follow-up study of patients with adrenal incidentalomas.
Libe, R., Dall'Asta, C., Barbetta, L., Baccarelli, A., Beck-Peccoz, P., & Ambrosi, B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470489 · Cited by 215
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Self-citationSubclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo, Osella, Alì, Borretta, Cesario, Paccotti, & Angeli, A. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00357.x · Cited by 198
Self-citationLate-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates1
Barzon, L., Scaroni, C. M., Sonino, N., Fallo, F., Gregianin, M., Macrì, C., & Boscaro, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4501 · Cited by 184
Feldkamp, Santen, Harms, Aulich, Mǒdder, & Scherbaum (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00748.x · Cited by 175
Development of overt Cushing’s syndrome in patients with adrenal incidentaloma
Barzon, L., Fallo, F., Sonino, N., & Boscaro, M. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460061 · Cited by 162
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients
Kasperlik‐Załuska, A. A., Rosłonowska, E., Słowińska‐Srzednicka, J., Migdalska, B., Jeske, W., Makowska, A., & Snochowska, H. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1751.x · Cited by 155 · cited 1×
“Kasperlik-Zaluska, 1997 [ 37 ] 208 5.2d 34 3.0c 17 2.9”
InfluentialThe diagnosis and differential diagnosis of Cushing's syndrome
Trainer, P. J., & Grossman, A. B. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03773.x · Cited by 155
Integrated imaging of adrenal disease.
Francis, I. R., Gross, M. D., Shapiro, B., KOROBKIN, M. T., & Quint, L. E. (1992) · Radiology · doi:10.1148/radiology.184.1.1609063 · Cited by 151
Chidiac, R. M., & Aron, D. C. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70242-5 · Cited by 140
Incidentally Discovered Adrenal Tumors: Endocrine and Scintigraphic Correlates
Barzon, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.55 · Cited by 140
A survey on incidental adrenal tumors in Japan
Aso, Y., & Homma, Y. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37601-2 · Cited by 136
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136 · cited 9×
“To circumvent the problem of false positivity of biochemical testing, some experts advocated that two concomitant alterations should be demonstrated to diagnose a patient who has subclinical Cushing’s syndrome [10,15,16,42].”
BackgroundInfluentialThe improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection
Midorikawa, S., Sanada, H., Hashimoto, S., Suzuki, T., & Watanabe, T. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01274.x · Cited by 134
Adrenal incidentalomas: a manifestation of the metabolic syndrome?
Reincke, M., Faßnacht, M., Väth, S., Mora, P., & Allolio, B. (1996) · Endocrine Research · doi:10.1080/07435809609043773 · Cited by 133
Subclinical hormone secretion by incidentally discovered adrenal masses
Caplan, R. H. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420270067016 · Cited by 133
Body Composition and Metabolic Features in Women with Adrenal Incidentaloma or Cushing's Syndrome
Garrapa, G., Pantanetti, P., Arnaldi, G., Mantero, F., & Faloia, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8059 · Cited by 132
Bülow, B., Ahrén, B., & the Swedish Research Council Study Group of Endocrine Abdominal Tumours (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01028.x · Cited by 120
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas
Barzon, L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.520 · Cited by 120
Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
Kojima, M., Morisaki, T., Tsukahara, Y., Uchiyama, A., Matsunari, Y., Mibu, R., & Tanaka, M. (1999) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199904)70:4 · Cited by 118
McLeod, M. K., Thompson, N. W., Gross, M. D., Bondeson, A. G., & Bondeson, L. (1990) · PubMed · Cited by 111
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00437.x · Cited by 109
Epidemiology of Cushing’s Syndrome and Subclinical Disease
Ross, N. S. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30082-3 · Cited by 104
Torlontano, M., Chiodini, I., Pileri, M., Guglielmi, G., Cammisa, M., Modoni, S., Carnevale, V., Trischitta, V., & Scillitani, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5856 · Cited by 91
Can Adrenal Incidentalomas Be Safely Observed?
Barry, M. K., van Heerden, J. A., Farley, D. R., Grant, C. S., Thompson, G. B., & Ilstrup, D. M. (1998) · World Journal of Surgery · doi:10.1007/s002689900441 · Cited by 87
Adrenal Insufficiency After Operative Removal of Apparently Nonfunctioning Adrenal Adenomas
Huiras, C. M. (1989) · JAMA · doi:10.1001/jama.1989.03420060110042 · Cited by 84
Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli, N., Catargi, B., Ronci, N., Vergnot, V, Leccia, F., Ferriere, J., Chene, G., Grenier, N., Laurent, F., & Tabarin, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440401 · Cited by 83
Chiodini, I., Guglielmi, G., Battista, C., Carnevale, V., Torlontano, M., Cammisa, M., Trischitta, V., & Scillitani, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031413 · Cited by 82
Tauchmanova, L., Rossi, R., Nuzzo, V, del Puente, A., Esposito-del Puente, A., Pizzi, C., Fonderico, F., Lupoli, G., & Lombardi, G. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450241 · Cited by 79
Different patterns of steroid secretion in patients with adrenal incidentaloma
Terzolo, M., Osella, G., Alı̀, A., Borretta, G., Magro, G., Termine, A., Paccotti, P., & Angeli, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636297 · Cited by 76
Self-citationIncidentalomas of the adrenal gland: 36 Operated patients and review of literature
Sirén, J. E., Haapiainen, R. K., Huikuri, K., & Sivula, A. H. (1993) · World Journal of Surgery · doi:10.1007/bf01659129 · Cited by 76
Tsagarakis, S., Roboti, C., Kokkoris, P., Vasiliou, V., Alevizaki, C., & Thalassinos, N. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00509.x · Cited by 75
Flecchla, D., Mazza, E., Carllni, M., Blatto, A., Ollvlerl, F., Serra:, G., Camannl, F., & Messlna, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01852.x · Cited by 75
Natural Course of Adrenal Incidentalomas: Seven‐year Follow‐up Study
Sirén, J., Tervahartiala, P. O., Sivula, A. H., & Haapiainen, R. K. (2000) · World Journal of Surgery · doi:10.1007/s002689910095 · Cited by 75
Bardet, S., Rohmer, V., Murat, A., Guillemot, C., Maréchaud, R., Chupin, M., Lecomte, P., Simon, D., Delemer, B., Schneebelli, S., et al. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.720541.x · Cited by 71
Bone loss rate in adrenal incidentalomas: a longitudinal study
Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8022 · Cited by 69
Seppel, T., & Schlaghecke, R. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02575.x · Cited by 63
Chiodini, I., Tauchmanovà, L., Torlontano, M., Battista, C., Guglielmi, G., Cammisa, M., Colao, A., Carnevale, V., Rossi, R., Di Lembo, S., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020399 · Cited by 63
Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
Bondanelli, M., Campo, M., Trasforini, G., Ambrosio, M. R., Zatelli, M. C., Franceschetti, P., Valentini, A., Pansini, R., & Uberti, E. C. D. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90176-1 · Cited by 61
Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas)
Jockenhövel, F., Kuck, W., Hauffa, B. P., Reinhardt, W., Benker, G., Lederbogen, S., Olbricht, T., & REINWEIN, D. (1992) · Journal of Endocrinological Investigation · doi:10.1007/bf03348745 · Cited by 61
Virkkala, A., Välimäki, M. J., Pelkonen, R., Huikuri, K., Kahri, A. I., Kivisaari, L., Korhonen, T., Salmi, J., & Seppälä, P. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1210067 · Cited by 58
Hensen, J., Buhl, M., Bähr, V., & Oelkers, W. (1990) · Journal of Molecular Medicine · doi:10.1007/bf01660959 · Cited by 57
The Adrenal Incidentaloma: Disease of Modern Technology and Public Health Problem
Aron, D. C. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1011580819132 · Cited by 56
Osella, G., Reimondo, G., Peretti, P., Alì, A., Paccotti, P., Angeli, A., & Terzolo, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7178 · Cited by 54
Self-citationHow Accurate Is Computed Tomography in Predicting the Real Size of Adrenal Tumors?
Linos, D. A. (1997) · Archives of Surgery · doi:10.1001/archsurg.1997.01430310054009 · Cited by 54
DIAGNOSIS AND TREATMENT OF ADRENAL INCIDENTALOMA
Kievit, J., & Haak, H. R. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70117-1 · Cited by 52
The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
Grossrubatscher, E., Vignati, F., Possa, M., & Loli, P. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343941 · Cited by 52
Incidentalomas of the adrenal gland: diagnostic and therapeutic implications.
Bastounis, E., Karayiannakis, A. J., Anapliotou, M. L. G., Nakopoulou, L., Makri, G. G., & Papalambros, E. L. (1997) · PubMed · Cited by 52
Bencsik, Z., Szabolcs, I., Kovács, Z., Ferencz, A., Vörös, A., Kaszás, I., Bor, K., Gönczi, J., Góth, M., Kovács, L., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626824 · Cited by 49
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 47
Self-citationKobayashi, S., Seki, T., Nonomura, K., Gotoh, T., Togashi, M., & Koyanagi, T. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35384-3 · Cited by 46
Agha, A., Liew, A., Finucane, F., Baker, L., O'Kelly, P., Tormey, W., & Thompson, C. J. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02035.x · Cited by 45
Rizza, R. A., Wahner, H. W., Spelsberg, T. C., Northcutt, R. C., & Moses, H. L. (1978) · PubMed · Cited by 40
Partially autonomous cortisol secretion by incidentally discovered adrenal adenomas
Lavoie, H. B., & Lacroix, A. (1995) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(95)00091-u · Cited by 37
Autonomy of cortisol secretion in clinically silent adrenal incidentaloma.
Tanabe, A., Naruse, M., Nishikawa, T., Yoshimoto, T., Shimizu, T., Seki, T., Takagi, S., Imaki, T., & Takano, K. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-16234 · Cited by 36 · cited 1×
“Favia, 2000 [44] 158 NR NR 5.1 NR 5.1 Tanabe, 2001 [ 45 ] 38 NR 26 47e 31 47”
InfluentialManagement of incidentally discovered adrenal masses
Murai, M., Baba, S., Nakashima, J., & Tachibana, M. (1999) · World Journal of Urology · doi:10.1007/s003450050098 · Cited by 34
Pre-Clinical Cushing’s Syndrome: Report of Three Cases and Literature Review
Fernández‐Real, J. M., Ricart, W., & Simó, R. (2008) · Hormone Research · doi:10.1159/000183930 · Cited by 33
Norton, J. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-68113-9 · Cited by 32
Favia, G., Lumachi, F., & D'Amico, D. F. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0024-5 · Cited by 32
Experience gained from operation of 103 adrenal incidentalomas
Proye, C. A. G., Manjili, M. J., Combemale, F., Pattou, F. N., Ernst, O., Carnaille, B. M. L., & Wémeau, J.-L. (1998) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050142 · Cited by 32
Preclinical Cushing’s syndrome: Report of seven cases and a review of the literature
Morioka, M., Fujii, T., Matsuki, T., Jo, Y., Kobayashi, T., Tanaka, H. Y., Ohashi, T., & Kondo, K. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00154.x · Cited by 28
Osella, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.604 · Cited by 24
Self-citationSubclinical Cushing's syndrome due to adrenal myelolipoma.
Boronat, M., Moreno, A., y Cajal, S. R., Pineda, E., Lucas, T., & Estrada, J. S. (1997) · PubMed · Cited by 23
Surgery: Basic Science and Clinical Evidence
Wilson, R. F. (2001) · doi:10.1097/00005373-200104000-00034 · Cited by 22
Allolio, B. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_18 · Cited by 10
Terzolo, M., Osella, G., Alı̀, A., & Angeli, A. (2000) · Endocrine updates · doi:10.1007/978-1-4615-4341-1_10 · Cited by 4
Self-citationA Follow-Up Evaluation of Patients with Incidentally Discovered Adrenal Adenoma
Bovio, S., Reimondo, G., Pia, A., Borretta, G., Lib, R., Dall??Asta, C., Cicala, V., Conton, P. A., Bemporad, D., Parenti, G. F., et al. (2005) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200512030-00074 · Cited by 2
Self-citation
Flagged first, then by citations
5 of the 100 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Self-citationFaßnacht, M., Tsagarakis, S., Terzolo, M., Tabarin, A., Sahdev, A., Newell-Price, J. D. C., Pelsma, I. C. M., Marina, L., Lorenz, K., Bancos, I., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad066 · Cited by 849
Self-citationAME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V., Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 523
Self-citationUrine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“Despite the absence of florid signs and symptoms, ACS in patients AI has been associated with hypertension (215), insulin resistance (216), type 2 diabetes mellitus (217), obesity (218), metabolic syndrome (219), and increased mortality (75).”
Background
Metadata
- Authors
- Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 34
- Issue
- 2
- Pages
- 423-439
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W2065618767
- Cited by
- 179
- References
- 100
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 11 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 10 · 2014: 6 · 2013: 10 · 2012: 18
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology and Metabolism Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- subclinical Cushing's syndrome, adrenal incidentaloma, adrenocortical hyperfunction, cortisol excess, adrenal adenoma
- MeSH terms
- Adrenal Cortex Neoplasms, Cushing Syndrome, Humans, Incidental Findings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
